The randomized controlled trial about the regression of atherosclerosis by using pioglitazone added to statin treatment
Not Applicable
- Conditions
- coronary artery disease
- Registration Number
- JPRN-UMIN000000480
- Lead Sponsor
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
anamnesis of cardiac insufficiency LVEF<40% critical hepatopathy(an increase the twice as many fiducial point of AST,ALT, ALP,etc, and choloplania) renal dysfunction(more than serum creatine 2.0mg/dl) anaphylactic anamnesis to piogritazon critical trauma, preoperative, serious infectious desease, pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method